Pursue Wealth Partners LLC Trims Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Pursue Wealth Partners LLC trimmed its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 5.3% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,569 shares of the financial services provider’s stock after selling 976 shares during the period. iShares Biotechnology ETF comprises 1.4% of Pursue Wealth Partners LLC’s holdings, making the stock its 25th largest position. Pursue Wealth Partners LLC’s holdings in iShares Biotechnology ETF were worth $2,558,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of IBB. Blue Fin Capital Inc. grew its holdings in iShares Biotechnology ETF by 0.7% in the second quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after purchasing an additional 74 shares during the period. Security National Bank of SO Dak grew its stake in iShares Biotechnology ETF by 0.7% in the 2nd quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after acquiring an additional 75 shares during the period. SPC Financial Inc. increased its holdings in iShares Biotechnology ETF by 2.4% in the 3rd quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after acquiring an additional 75 shares in the last quarter. Werba Rubin Papier Wealth Management raised its position in iShares Biotechnology ETF by 2.7% during the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after acquiring an additional 76 shares during the period. Finally, Main Street Financial Solutions LLC lifted its holdings in iShares Biotechnology ETF by 1.0% during the second quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock valued at $1,098,000 after purchasing an additional 82 shares in the last quarter. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Down 1.5 %

Shares of NASDAQ IBB opened at $140.29 on Friday. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $150.57. The firm has a 50-day simple moving average of $145.24 and a 200-day simple moving average of $140.27.

iShares Biotechnology ETF Announces Dividend

The firm also recently announced a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.